Tag Archives: biotechnology law

Supreme Court Decides Bowman v. Monsanto for Monsanto

Posted on May 15, 2013 by Warren Woessner

On May 13th, a unanimous Court found that the doctrine of patent exhaustion “does not allow the purchaser to make new copies of the patented invention.” [A copy of decision is at the end of this post.] In this case, the patented … Continue reading →

Posted in Ag Biotechnology | Tagged , , , , , , , , | 1 Comment

CLS Bank v. Alice Corp. (Part 2)

Posted on May 14, 2013 by Warren Woessner

I hope that some of my loyal readers noticed that my last post on CLS was incomplete, since it did not elaborate on the rationale for the decision(s) arrived at by the majority, either directly or by default. The first … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , | Leave a comment

En (many) banc(s) Fed. Cir. decides CLS Bank v. Alice Corp. (Part 1)

Posted on May 13, 2013 by Warren Woessner

On May 10th, the Federal Circuit issued a short per curium opinion affirming the district court’s decision that “a majority of the court affirms the [holding below] that the asserted method and computer-readable media claims are not directed to eligible … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , | Leave a comment

Complimentary Webinar: Bringing Biotech Innovation to Market

Posted on May 9, 2013 by Warren Woessner

Schwegman Lundberg & Woessner, P.A. and Cornell University have teamed up to give you the latest developments in “Bringing Biotech Innovation to Market.”  The live webinar will be presented on Friday, May 17th @ 12 PM (EDT).  For more information … Continue reading →

Posted in Webinar | Tagged , , , | Leave a comment